首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1629600

药物传输技术市场：依给药途径、依治疗领域、依最终使用者、按地区

Drug Delivery Technologies Market, By Route of Administration, By Therapeutic Area, By End User, By Geography

出版日期: 2024年12月06日 | 出版商:

Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球给药技术市场规模为441亿美元，预计2031年将达1,020.1亿美元，2024年至2031年复合年增长率为12.7%。

报告范围		报告详情
基准年	2023年	2024年市场规模	441亿美元
实际资料	2019-2023	预测期	2024-2031
预测 2024-2031 年复合年增长率：	12.70%	2031年价值预测	1020.1亿美元

图：2024 年按地区分類的药物输送技术市场占有率(%)

药物递送是指在体内运输药物化合物以安全地获得所需治疗效果的方法、製剂、技术和系统。人们已经开发了各种药物递送技术，透过保护药物分子免于降解和控制释放速率来提高功效和安全性。免疫疗法、基因疗法和精准医学等领域的进步正在推动对更有效的药物传递方法的需求。市场正在见证新型药物载体系统的创新，例如脂质体、微球和奈米载体，它们可以有效地将药物输送到体内的目标部位。此外，慢性病盛行率上升、生技药品市场成长以及该领域主要企业研发投资的增加是预计在预测期内推动市场成长的一些关键因素。

市场动态：

全球药物传输技术市场主要受到癌症、糖尿病和心血管疾病等慢性病全球盛行率上升的推动。根据世界卫生组织 (WHO) 2023 年 9 月的数据，慢性病约占 2020 年全球通报死亡人数的 60%。药物输送系统有助于提高慢性疾病患者药物治疗的有效性和临床结果。此外，生技药品市场的成长也为大分子生物疗法药物的先进给药方法创造了机会。然而，与新型药物输送系统的研发和製造相关的高成本可能会阻碍预测期内的市场成长。奈米医学、注射给药和 3D 列印领域的进步为市场扩张提供了利润丰厚的机会。

本研究的主要特点

本报告对全球给药技术市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。

它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、主要亮点、业务绩效和策略等参数，对全球药物输送技术市场的主要企业进行概况分析。

主要公司包括强生公司、辉瑞公司、诺华公司、默克公司、葛兰素史克公司、赛诺菲公司、拜耳公司、雅培公司、3M公司、Antares Pharma、Alkermes PLC、Vectura Group PLC、Generex生物技术公司、F. Hoffmann-La Roche Ltd. 和Medtronic PLC。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球药物输送技术市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球药物输送技术市场的各种策略矩阵，将有助于相关人员做出决策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 44.10 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	12.70%	2031 Value Projection:	US$ 102.01 Bn

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Various drug delivery technologies have been developed to improve efficacy and safety of drug molecules by protecting them from degradation and controlling their release rates. Advancements in areas such as immunotherapy, gene therapy, and precision medicine have fueled the demand for more effective drug delivery methods. The market has witnessed innovation of novel drug carrier systems such as liposomes, microspheres, nanocarriers, and other that can efficiently deliver drugs to targeted sites in the body. Furthermore, rising prevalence of chronic diseases, growth of biologics market, and increased R&D investments from key players in this field are some of the key factors expected to drive market growth during the forecast period.

Market Dynamics:

Global drug delivery technologies market is primarily driven by the rising global prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. In September 2023, according to the World Health Organization (WHO), chronic diseases accounted for approximately 60% of all reported deaths in the world in 2020. Drug delivery systems help improve the efficacy of pharmaceutical therapies and clinical outcomes of chronic patients. Furthermore, growth of the biologics market has also created opportunities for advanced drug delivery approaches for large molecule biotherapeutics. However, high costs associated with the R&D and manufacturing of novel drug delivery systems may hinder the market growth during the forecast period. Advancements in areas of nanomedicine, injectable drug delivery, and 3D printing offer lucrative opportunities for market expansion.

Key Features of the Study:

This report provides in-depth analysis of the global drug delivery technologies market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global drug delivery technologies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Johnson & Johnson Pvt. Ltd., Pfizer Inc., Novartis AG, Merck & Co., Inc., GlaxoSmithKline PLC, Sanofi S.A., Bayer AG, Abbott Laboratories, 3M Company, Antares Pharma, Alkermes PLC, Vectura Group PLC, Generex Biotechnology Corporation, F. Hoffmann-La Roche Ltd., and Medtronic PLC

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global drug delivery technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery technologies market

Market Segmentation

Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Intramuscular
- Intravenous
- Intra-Arterial
- Subcutaneous
- Nasal Drug Delivery
- Ocular Drug Delivery
- Topical/Transdermal
Therapeutic Area Insights (Revenue, USD Bn, 2019 - 2031)
- Oncology
- Cardiology
- Neurology
- Immunology
- Rheumatology
- Diabetes
- Others (Infectious Diseases, etc.)
End User Insights (Revenue, USD Bn, 2019 - 2031)
- Ambulatory Surgical Clinics
- Diagnostic Centers
- Hospitals
- Homecare Settings
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Johnson & Johnson Pvt. Ltd.
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- GlaxoSmithKline PLC
- Sanofi S.A.
- Bayer AG
- Abbott Laboratories
- 3M Company
- Antares Pharma
- Alkermes PLC
- Vectura Group PLC
- Generex Biotechnology Corporation
- F. Hoffmann-La Roche Ltd.
- Medtronic PLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Drug Delivery Technologies Market, By Route of Administration
- Global Drug Delivery Technologies Market, By Therapeutic Area
- Global Drug Delivery Technologies Market, By End User
- Global Drug Delivery Technologies Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Drug Delivery Technologies Market, By Route of Administration, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Intramuscular
- Intravenous
- Intra-Arterial
- Subcutaneous
Nasal Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ocular Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Topical/Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Drug Delivery Technologies Market, By Therapeutic Area, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Rheumatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Infectious Diseases, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Drug Delivery Technologies Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Ambulatory Surgical Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Drug Delivery Technologies Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Route of Administration , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Route of Administration , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Route of Administration , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Johnson & Johnson Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
Novartis AG
Merck & Co., Inc.
GlaxoSmithKline PLC
Sanofi S.A.
Bayer AG
Abbott Laboratories
3M Company
Antares Pharma
Alkermes PLC
Vectura Group PLC
Generex Biotechnology Corporation
F. Hoffmann-La Roche Ltd.
Medtronic PLC

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

药物传输技术市场：依给药途径、依治疗领域、依最终使用者、按地区